Target RNA activates the protease activity of Craspase to confer antiviral defense.
Liu, X., Zhang, L., Wang, H., Xiu, Y., Huang, L., Gao, Z., Li, N., Li, F., Xiong, W., Gao, T., Zhang, Y., Yang, M., Feng, Y.(2022) Mol Cell 82: 4503-4518.e8
- PubMed: 36306795 
- DOI: https://doi.org/10.1016/j.molcel.2022.10.007
- Primary Citation of Related Structures:  
7XSO, 7XSP, 7XSQ, 7XSR, 7XSS, 7XT4 - PubMed Abstract: 
In the type III-E CRISPR-Cas system, a Cas effector (gRAMP) is associated with a TPR-CHAT to form Craspase (CRISPR-guided caspase). However, both the structural features of gRAMP and the immunity mechanism remain unknown for this system. Here, we report structures of gRAMP-crRNA and gRAMP:cRNA:target RNA as well as structures of Craspase and Craspase complexed with cognate target RNA (CTR) or non-cognate target RNA (NTR) ...